This positive development followed the US Food and Drug Administration (US FDA) issuing an Establishment Inspection Report (EIR) for the facility, bringing the regulatory inspection to a close.
According to the company’s stock exchange filing, the USFDA conducted a current Good Manufacturing Practices (cGMP) inspection at the facility from May 12 to May 20, 2026. The inspection concluded with a Form 483 containing five observations, to which Strides submitted a comprehensive response within the stipulated timeframe.
Following a review of the company’s responses and the corrective and preventive actions implemented, the USFDA classified the inspection outcome as Voluntary Action Indicated (VAI) and issued the EIR, effectively concluding the inspection process.
The Bengaluru facility is Strides’ flagship manufacturing site and caters to regulated as well as other international markets. It manufactures a wide range of pharmaceutical dosage forms, including tablets, capsules and oral liquids, supporting both existing commercial products and the company’s future growth plans.
Stock Performance and Valuation
The USFDA development comes as a relief for investors after a period of weakness in the stock. Before Thursday’s sharp recovery, Strides Pharma Science shares had declined around 10% over the past month and nearly 16% over the last three months. At Thursday’s level, the company’s market capitalisation stood at approximately Rs 8,825 crore, while the stock’s 52-week high is Rs 1,231.## Technical Indicators
Technically, the stock continues to show signs of recent weakness despite Thursday’s strong rebound. Its 14-day Relative Strength Index (RSI) stands at 36.3. An RSI below 30 generally indicates oversold conditions, while a reading above 70 is viewed as overbought.The stock is currently trading above six of its eight key Simple Moving Averages (SMAs), while remaining below its 50-day and 100-day SMAs. The technical setup suggests that Thursday’s rally could mark an attempt at recovery, although the stock still needs to regain key moving-average levels to establish stronger upward momentum.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)
Subscribe to ET Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)
Subscribe to ET Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price